Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.
about
Renal dopaminergic system: Pathophysiological implications and clinical perspectivesRisks of a lifetime in construction. Part II: chronic occupational diseasesRisks of a lifetime in construction. Part I: traumatic injuriesPopulation-level interventions in government jurisdictions for dietary sodium reductionEffect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trialsEstimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in CanadaPublic education on hypertension: a new initiative to improve the prevention, treatment and control of hypertension in CanadaStudy of urban community survey in India: growing trend of high prevalence of hypertension in a developing country.Differential susceptibility to hypertension is due to selection during the out-of-Africa expansionAge as a risk factorElderly hypertensives: how are they different?What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendationsManaging hypertension in the elderly: a common chronic disease with increasing ageApproach to preventive care in the elderlyAborder les soins préventifs chez les aînésJNC 7 category and risk of cardiovascular death in men: are there differences by age?Heart disease and stroke statistics--2014 update: a report from the American Heart AssociationStroke Risk Factors, Genetics, and Prevention.[Epidemiology of hypertension: Prevalence, Awareness and Treatment].Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective.The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry.Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.Structural imaging measures of brain aging.Does Age Matter? Association Between Usual Source of Care and Hypertension Control in the US Population: Data From NHANES 2007-2012Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart StudyUsing an age-at-onset phenotype with interval censoring to compare methods of segregation and linkage analysis in a candidate region for elevated systolic blood pressure.An estimating equation approach to dimension reduction for longitudinal data.Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.Drug interactions with angiotensin receptor blockers.Effect of "no added salt diet" on blood pressure control and 24 hour urinary sodium excretion in mild to moderate hypertension.Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.Symptoms associated with an abnormal echocardiogram in elderly primary care hypertension patients.Evaluating the Framingham hypertension risk prediction model in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study.Impact of prehypertension on left ventricular mass and QT dispersion in adult black NigeriansHeritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart StudyA cohort study of incident hypertension in relation to changes in vigorous physical activity in men and women.Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failureRacial and ethnic differences in hypertension risk: new diagnoses after age 50Methods to estimate underlying blood pressure: The Atherosclerosis Risk in Communities (ARIC) Study.Hypertension: are you and your patients up to date?
P2860
Q22241156-1CC3CCA9-5361-415C-A90E-E94FBBBB922FQ23916331-63C8E2A5-17EC-485C-9F14-6FD747A0D554Q23923955-FE9DBF0C-4F8D-4834-9669-CED86379EAB0Q24199147-82E03074-11E5-46CB-A956-03C45BA7D862Q24563840-790E37FA-AEEA-432D-98E3-DD8A80A3ED5DQ24645546-A045BFE2-F32D-4844-9DA3-1BE568D135A1Q24658005-B22E88E9-F6A8-4C5A-BED2-330E44B7C5BDQ24810333-0F8CBAE1-35F7-45C4-8120-F0B12D5C6851Q25255837-BF6A0DBE-D126-4D9A-907D-4AA55E6464F2Q26827274-61AF01D7-D431-45E3-8557-7932135C1808Q26830725-75D889AC-3E53-4C6A-809B-CA3EE5B8B1DAQ26864349-24F49E87-EAC0-4F48-8414-2501CE8849A8Q27011805-C9F8CDCA-5B2C-4B75-A5C7-4A22FBB24AA5Q28069648-F5CE8419-92D8-4E79-8CDE-FBF59CC4E44DQ28077487-15EA10B1-4727-4E78-A0DB-440C0FFF8130Q28175242-A3BB7752-8C2D-45D8-B4CB-0AA54BBEC755Q29547691-64C87166-0642-48DC-88FD-48D75402B391Q30238633-A695304F-76E5-4FAC-BC08-181E7A7F85F5Q30244858-C6CED91E-98FA-4307-90BF-F981BF4C07B6Q30245667-C22D2E0F-C382-4A6E-A969-F533EFA2503EQ30615846-20421C78-0C47-46F4-8E5A-5F31776039AEQ30619473-688BC7D8-000F-4D5E-94BA-99BDD3067A67Q30844186-0294D3E9-FC72-4001-8B2D-4B83350288D9Q31046561-BAA73019-048D-48E1-B800-89843901EC0BQ31049155-05937396-D361-420B-9D95-12D4E37C7215Q31049159-83A885BC-5265-4A34-B913-0B213530B856Q31063820-DF4D4B67-22A6-4A46-AB59-1AD72218DE73Q31152110-2B9100F4-FF21-4958-A5AC-44DC4BB26922Q33211891-E0E650D0-0244-4FED-99C2-969F4891E327Q33305137-80B19995-9D4D-4D15-8724-78C568087506Q33561456-5DB01F0B-414A-4A05-A6FE-AB1C6361C081Q33591746-B8CA6A40-C75E-4666-852D-8436431CE1CFQ33605132-AC2A4BBB-841A-443B-914B-561C17E1FCF1Q33634050-23C195E0-039B-448C-8739-51338923D819Q33681394-819AE05F-79D1-43A8-99B5-A64B02A162FBQ33687730-B9AC4768-2F72-455E-91C8-5B68D4AE14DEQ33810217-FFD35946-AAE5-4269-964A-5CF527743379Q33855146-DF288B39-7579-4080-AA2A-6AA552644170Q33898165-C5875209-5422-419B-8212-494698D04D2BQ33916689-75F32FF0-BE2E-423F-A4D7-B69133F1AD45
P2860
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@ast
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@en
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@nl
type
label
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@ast
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@en
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@nl
prefLabel
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@ast
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@en
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@nl
P2093
P50
P356
P1476
Residual lifetime risk for dev ...... n: The Framingham Heart Study.
@en
P2093
Daniel Levy
Ralph B D'Agostino
William B Kannel
P304
P356
10.1001/JAMA.287.8.1003
P407
P577
2002-02-01T00:00:00Z